Improved survival in several cancers with use of H(1)-antihistamines desloratadine and loratadine

BACKGROUND: We have previously shown an association with substantially improved survival in breast cancer and melanoma for desloratadine and loratadine users, and set out to find whether an improved survival can be seen in tumors with and without a known response to immune checkpoint therapy, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritz, Ildikó, Wagner, Philippe, Olsson, Håkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868613/
https://www.ncbi.nlm.nih.gov/pubmed/33550204
http://dx.doi.org/10.1016/j.tranon.2021.101029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868613/
https://www.ncbi.nlm.nih.gov/pubmed/33550204
http://dx.doi.org/10.1016/j.tranon.2021.101029

Ejemplares similares